Massive haemorrhage induced by low molecular weight heparin in a patient with steroid refractory ulcerative colitis

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 6, 2004, Pages 613-

  Kaya, S ^a   Hatemi, I ^a   Hamzaoglu, I ^a   Uzunismail, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; LOW MOLECULAR WEIGHT HEPARIN; MESALAZINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; ANAMNESIS; BLEEDING; CASE REPORT; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HUMAN; LETTER; PANCYTOPENIA; PRIORITY JOURNAL; SEDIMENTATION RATE; ULCERATIVE COLITIS;

ADULT; ANTICOAGULANTS; COLITIS, ULCERATIVE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; NADROPARIN; RECTUM;

EID: 3142784483     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410004622     Document Type: Letter

References (5)

1. Vrij AA, Jansen JM, Schoon EJ, de Bruine A, Hemker HC, Stockbrugger RW. Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi. Scand J Gastroenterol 2001;Suppl 234:41-7.
2. Dotan I, Hallak A, Arber N, Santo M, Alexandrowitz A, Knaani Y, et al. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci 2001;46:2239-44.
3. Torkvist L, Thorlacius H, Sjoqvist U, Bohman Z, Lapidus A, Flood L, et al. Low molecular weight heparin as adjuvant therapy in active ulcerative colitis. Aliment Pharmacol Ther 1999;13: 1323-8.
4. Panes J, Esteve M, Cabre E, Hinafosul J, Andreu M, Sars M, et al. Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis. Gastroenterology 2000;119:903-8.
5. Folwaczny C, Wiebecke B, Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol 1999;94:1551-5.